Changes in the atherogenic risk factor profile according to degree of weight loss

被引:222
作者
Reinehr, T [1 ]
Andler, W [1 ]
机构
[1] Univ Witten Herdecke, Vest Kinderklin, D-45711 Datteln, Germany
关键词
D O I
10.1136/adc.2003.028803
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The atherogenic risk factor profile in obese subjects is characterised by hypertension, reduced high density lipoprotein (HDL) cholesterol, increased low density lipoprotein (LDL) cholesterol and triglycerides, and insulin resistance. Aims: To examine the amount of weight reduction required to improve the atherogenic profile. Methods: Changes of systolic and diastolic blood pressure, HDL and LDL cholesterol, triglycerides, and insulin resistance, based on the HOMA model over a one year period were studied in obese children, who attended the intervention programme "Obeldicks''. The children were divided into four groups according to the change in body mass index standard deviation score (SDS-BMI): group I, increase in SDS-BMI; group II, decrease in SDS-BMI <0.25; group III, decrease in SDS-BMI >= 0.25 -<0.5; group IV, decrease in SDS-BMI greater than or equal to0.5. Results: A total of 130 children (mean age 10.7 years, range 4 - 15; mean SDS-BMI 2.5, range 2.0 - 4.0) were studied. The four groups did not differ in age, gender, or degree of overweight (SDS-BMI). An increasing SDS-BMI ( group I: n = 20) was followed by a significant increase in insulin resistance ( HOMA). Systolic and diastolic blood pressure, LDL cholesterol, triglycerides, and insulin resistance ( HOMA) decreased significantly while HDL cholesterol increased significantly in group IV ( n = 37). LDL cholesterol also decreased significantly in group III ( n = 40); there was no significant change of the other parameters in groups I, II, and III. Conclusion: Over a time period of one year increasing weight in obese children leads to an increase in insulin resistance. Weight loss is associated with an improvement in the atherogenic profile and in insulin resistance, but only if the SDS-BMI decreases by at least 0.5 over a one year period.
引用
收藏
页码:419 / 422
页数:4
相关论文
共 37 条
[1]  
[Anonymous], 1987, Pediatrics, V79, P1
[2]   Insulin sensitivity, lipids, and body composition in childhood: Is ''syndrome X'' present? [J].
Arslanian, S ;
Suprasongsin, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) :1058-1062
[3]   Obesity evaluation and treatment: Expert committee recommendations [J].
Barlow, SE ;
Dietz, WH .
PEDIATRICS, 1998, 102 (03)
[4]   Prevalence of insulin resistance in metabolic disorders - The Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Targher, G ;
Alberiche, M ;
Bonadonna, RC ;
Muggeo, M .
DIABETES, 1998, 47 (10) :1643-1649
[5]  
COLE TJ, 1990, EUR J CLIN NUTR, V44, P45
[6]   Establishing a standard definition for child overweight and obesity worldwide: international survey [J].
Cole, TJ ;
Bellizzi, MC ;
Flegal, KM ;
Dietz, WH .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7244) :1240-1243
[7]   Presence of metabolic cardiovascular syndrome in obese children [J].
Csábi, G ;
Török, K ;
Jeges, S ;
Molnár, D .
EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (1-2) :91-94
[8]   Efficacy and safety of statin therapy in children with familial hypercholesterolemia -: A randomized, double-blind, placebo-controlled trial with simvastatin [J].
de Jongh, S ;
Ose, L ;
Szamosi, T ;
Gagné, C ;
Lambert, M ;
Scott, R ;
Perron, P ;
Dobbelaere, D ;
Saborio, M ;
Tuohy, MB ;
Stepanavage, M ;
Sapre, A ;
Gumbiner, B ;
Mercuri, M ;
van Trotsenburg, ASP ;
Bakker, HD ;
Kastelein, JJP .
CIRCULATION, 2002, 106 (17) :2231-2237
[9]   The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation [J].
Dirisamer, A ;
Hachemian, N ;
Bucek, RA ;
Wolf, F ;
Reiter, M ;
Widhalm, K .
EUROPEAN JOURNAL OF PEDIATRICS, 2003, 162 (06) :421-425
[10]   Childhood obesity: public-health crisis, common sense cure [J].
Ebbeling, CB ;
Pawlak, DB ;
Ludwig, DS .
LANCET, 2002, 360 (9331) :473-482